Sign up
Pharma Capital

Motif Bio gearing up to present at major conference on infectious diseases

Graham Lumsden, chief executive of Motif Bio Plc (LON:MTFB), tells Proactive they've got a busy week lined up in early October, when they'll be presenting at the annual Infectious Diseases conference.

The clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that three abstracts have been accepted for poster presentations at the Infectious Diseases Week Annual Meeting in San Diego 4-8 October 2017. 

''Infectious Diseases week is a major conference. About 6,000 healthcare professionals usually attend so it's a good place for us to have a presence and  continue to build awareness and knowledge around iclaprim'', Lumsden says.

 

View full MTFB profile

Motif Bio Plc Timeline

Article

Motif Bio : The home plate beckons

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.